<DOC>
	<DOC>NCT00664638</DOC>
	<brief_summary>To investigate the clinical utility of renal denervation in the treatment of refractory hypertension.</brief_summary>
	<brief_title>Renal Denervation in Patients With Refractory Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>&gt;= 18 years of age a systolic blood pressure of 160mmHg or more receiving and adhering to full doses of at least three antihypertensive drugs estimated glomerular filtration rate (eGFR) of â‰¥45mL/min agrees to have the study procedure(s) performed and additional procedures and evaluations is competent and willing to provide written, informed consent to participate in this clinical study hemodynamically or anatomically significant renal artery stenosis has a history or prior renal artery angioplasty has experienced MI, unstable angina pectoris, or CVA within 6 months has hemodynamically significant valvular heart disease has Type 1 diabetes has an implantable cardioverter defibrillator (ICD) or pacemaker, or any other metallic implant which is not compatible with magnetic resonance imaging (MRI) requires respiratory support is pregnant, nursing, or planning to be pregnant has known, unresolved history of drug use or alcohol dependency. is currently enrolled in another investigational drug or device trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>